County Of Champaign Community Unit School District No 1 Clinic/Center - Student Health Medicare: Not Enrolled in Medicare Practice Location: 801 S. Fifth Street, Fisher, IL 61843 Phone: 217-897-6125 Fax: 217-897-6676 |
Family Healthcare Of Fisher General Practice Medicare: Not Enrolled in Medicare Practice Location: 104 S 3rd St, Fisher, IL 61843 Phone: 217-897-1692 Fax: 217-897-6027 |
News Archive
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Apes bite and try to break a tube to retrieve the food inside while children follow the experimenter's example to get inside the tube to retrieve the prize, showing that even before preschool, toddlers are more sophisticated in their social learning skills than their closest primate relatives, according to a report published in the 7 September issue of the journal Science , published by AAAS, the nonprofit science society.
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, was granted Fast Track designation by the U.S. Food and Drug Administration for perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of refractory advanced colorectal cancer.
› Verified 9 days ago